Search research articles
Contact Us
Filters
Showing results (671-680 of 754) with videos related to
Page
of 76
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
July 28, 2023
Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial
In Ah Kim, Kathryn A Winter, Paul W Sperduto, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 9, 2020
NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update
William Small, Walter R Bosch, Mathew M Harkenrider, et al.
JAMA Network Open
|
November 16, 2022
Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy
Anthony M Magliocco, Jennifer Moughan, David T Miyamoto, et al.
Journal of Medicinal Chemistry
|
September 20, 2002
Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine
Sandra A Filla, Mark A Winter, Kirk W Johnson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Image-Guided Radiation Therapy Committee
J Michalski, J A Purdy, L Gaspar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 12, 2020
Clofazimine for Treatment of Cryptosporidiosis in Human Immunodeficiency Virus Infected Adults: An Experimental Medicine, Randomized, Double-blind, Placebo-controlled Phase 2a Trial
Py Iroh Tam, S L M Arnold, L K Barrett, et al.
Journal of the National Cancer Institute
|
September 10, 2024
Quality-of-life outcomes from NRG Oncology NSABP B-39/RTOG 0413: whole-breast irradiation vs accelerated partial-breast irradiation after breast-conserving surgery
Patricia A Ganz, Reena S Cecchini, Julia R White, et al.
Nature Communications
|
June 13, 2023
Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection
Sunil K Ahuja, Muthu Saravanan Manoharan, Grace C Lee, et al.
JAMA Network Open
|
April 21, 2023
Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials
Christopher L Hallemeier, Jennifer Moughan, Michael G Haddock, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 15, 2013
GluK1 antagonists from 6-(carboxy)phenyl decahydroisoquinoline derivatives. SAR and evaluation of a prodrug strategy for oral efficacy in pain models
Jose A Martinez-Perez, Smriti Iyengar, Harlan E Shannon, et al.
Page
of 76
Search research articles
Search
Showing results (671-680 of 754) with videos related to
Sort By:
Page
of 76
International Journal of Radiation Oncology, Biology, Physics
|
July 28, 2023
Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial
In Ah Kim, Kathryn A Winter, Paul W Sperduto, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 9, 2020
NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update
William Small, Walter R Bosch, Mathew M Harkenrider, et al.
JAMA Network Open
|
November 16, 2022
Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy
Anthony M Magliocco, Jennifer Moughan, David T Miyamoto, et al.
Journal of Medicinal Chemistry
|
September 20, 2002
Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine
Sandra A Filla, Mark A Winter, Kirk W Johnson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Image-Guided Radiation Therapy Committee
J Michalski, J A Purdy, L Gaspar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 12, 2020
Clofazimine for Treatment of Cryptosporidiosis in Human Immunodeficiency Virus Infected Adults: An Experimental Medicine, Randomized, Double-blind, Placebo-controlled Phase 2a Trial
Py Iroh Tam, S L M Arnold, L K Barrett, et al.
Journal of the National Cancer Institute
|
September 10, 2024
Quality-of-life outcomes from NRG Oncology NSABP B-39/RTOG 0413: whole-breast irradiation vs accelerated partial-breast irradiation after breast-conserving surgery
Patricia A Ganz, Reena S Cecchini, Julia R White, et al.
Nature Communications
|
June 13, 2023
Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection
Sunil K Ahuja, Muthu Saravanan Manoharan, Grace C Lee, et al.
JAMA Network Open
|
April 21, 2023
Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials
Christopher L Hallemeier, Jennifer Moughan, Michael G Haddock, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 15, 2013
GluK1 antagonists from 6-(carboxy)phenyl decahydroisoquinoline derivatives. SAR and evaluation of a prodrug strategy for oral efficacy in pain models
Jose A Martinez-Perez, Smriti Iyengar, Harlan E Shannon, et al.
Page
of 76